Hht Foundation International is ranked among community improvement organizations in Cockeysville, MD, with an America's Best Score of 79 out of 100, based on its 2025 Form 990.
Hht Foundation International, inc. Is a not-for-profit organization dedicated to serving individuals affected by hereditary hemorrhagic telangiectasia (hht). The organization provides information to patients, family members, and healthcare professionals; offers support and community for patients and their families; raises funds to advance basic and clinical research; and sponsors research grants to promote scientific studies focused on hht.
Largest programs · fiscal year 2025
Research - the research program supports funding for studies that advance understanding of the underlying mechanisms of hht, fosters the development of novel therapeutic approaches for treatment and disease management, and promotes translational research that leads to multi-center clinical trials. In addition, the hht international scientific conference is held biennially to facilitate collaborati… Read more
Research - the research program supports funding for studies that advance understanding of the underlying mechanisms of hht, fosters the development of novel therapeutic approaches for treatment and disease management, and promotes translational research that leads to multi-center clinical trials. In addition, the hht international scientific conference is held biennially to facilitate collaboration and the exchange of scientific knowledge among researchers and clinicians.
$5,435,882 spent · 88.4% of program spending
Education - the goal of the education program is to advance awareness, accurate diagnosis, and best-practice treatment of hht by supporting patient education and outreach, sponsoring educational conferences and professional meetings, and strengthening a network of comprehensive hht clinical centers of excellence.$390,312 spent · 6.4% of program spending
Public information - the goal of the public information program is to increase awareness of hereditary hemorrhagic telangiectasia (hht) among the general public, private sector, and governmental audiences through strategic engagement with the press and other media channels.$290,891 spent · 4.7% of program spending
Advocacy - the goal of the advocacy program is to represent and support individuals affected by hht by advancing recognition of the disorder and securing funding to expand awareness efforts, improve access to expert care, and promote participation in clinical trials.$29,023 spent · 0.5% of program spending
Where each dollar went · fiscal year 2025
Of every dollar it spent, 86¢ went to programs, 9¢ to management and 5¢ to fundraising.
Programs $6,146,108
Management $612,535
Fundraising $370,532
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
86%
Meets
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$9,841,516Fiscal year 2025
Expenses$7,129,175Fiscal year 2025
Total assets$8,133,180Fiscal year 2025
Total liabilities$962,042Fiscal year 2025
Fiscal year ending June2025
Revenue$9,841,516
Expenses$7,129,175
Net income$2,712,341
Net assets$7,171,138
Notable sources of revenue
Percent of total revenue
Contributions
$9,245,580
93.9%
Program services
$470,997
4.8%
Investment income
$134,970
1.4%
Other (net)
−$10,031
−0.1%
Assets / debt
Total assets
$8,133,180
Total liabilities
$962,042
Net assets
$7,171,138
Compensation
Not in our extract for this year.
Fiscal year ending June2024
Revenue$6,790,311
Expenses$5,251,461
Net income$1,538,850
Net assets$4,404,410
Notable sources of revenue
Percent of total revenue
Contributions
$6,587,947
97.0%
Program services
$104,766
1.5%
Investment income
$134,583
2.0%
Other (net)
−$36,985
−0.5%
Assets / debt
Total assets
$5,213,609
Total liabilities
$809,199
Net assets
$4,404,410
Compensation
Not in our extract for this year.
Fiscal year ending June2023
Revenue$3,740,865
Expenses$4,069,058
Net income−$328,193
Net assets$2,835,411
Notable sources of revenue
Percent of total revenue
Contributions
$3,263,861
87.2%
Program services
$410,107
11.0%
Investment income
$55,714
1.5%
Other (net)
$11,183
0.3%
Assets / debt
Total assets
$3,515,746
Total liabilities
$680,335
Net assets
$2,835,411
Compensation
Officers and key employees
$289,541
Share of expenses
7.1%
Fiscal year ending June2022
Revenue$2,377,085
Expenses$1,884,387
Net income$492,698
Net assets$3,144,605
Notable sources of revenue
Percent of total revenue
Contributions
$2,356,154
99.1%
Program services
$23,936
1.0%
Investment income
$13,736
0.6%
Other (net)
−$16,741
−0.7%
Assets / debt
Total assets
$3,323,287
Total liabilities
$178,682
Net assets
$3,144,605
Compensation
Officers and key employees
$311,048
Share of expenses
16.5%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?